Unilever Acquires Dr. Squatch to Expand Its Men’s Personal Care Business
Unilever has signed an agreement to acquire men’s personal care brand Dr. Squatch from private equity firm Summit Partners, marking its strategic entry into the premium natural beauty products sector.
Known for its natural ingredient formulas and unique scents, Dr. Squatch is primarily targeted at men and offers soaps, shower gels, deodorants and care products. The brand has grown through a strong direct sales model, social media and influencer marketing.
With its primary markets in North America and some distribution in Europe, Dr. Squatch operates through retail, e-commerce and direct sales channels. Unilever has not disclosed the financial terms of the transaction, which is expected to close later this year, subject to regulatory approvals.
The acquisition strengthens Unilever’s position in men’s personal care, particularly in the high-growth, premium-positioned digitally native brand space. As consumers increasingly demand natural, purpose-driven products, Dr. Squatch will bring product innovation and a digital consumer base to Unilever’s portfolio.
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Unilever Sells Kate Somerville Brand to Rare Beauty Brands
-
Unilever Invests 30 Billion Forints in New Deodorant Plant in Hungary
-
Unilever to Invest $1.5 Billion in New Beauty and Personal Care Product Plant in Mexico
-
Unilever's Basic Sales Increased by 3% in the First Quarter of 2025
-
Unilever Acquires Refillable Personal Care Brand Wild
-
Unilever is Rumored to Be Buying Wild for £230 Million
-
Unilever's Indonesian Market Share Drops Due to Boycott
-
Unilever and NUFARM partner on ‘crops of the future’
-
Unilever to invest €100 million in fragrance development
Recommend Reading
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation
-
Cost Decline, Weak Demand—Oxynol Prices Fluctuate and Fall This Week
-
US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes
-
July Titanium Dioxide Market Prices Decline
-
In July, China's propylene oxide market showed a trend of first declining, then rising, and finally surging before stabilizing